In yet another costcutting move the DePuy Synthes medical device unit of Johnson  Johnson is eliminating all travel  except for its sales force  for the rest of the year in hopes of lowering such costs by  and meeting  financial goals according to an internal memo At the same time all consulting contracts valued at more than  must now obtain toplevel approval This is the second time in recent weeks that DePuy Synthes which represents the largest portion of the  billion JJ device business has cut costs Late last month the unit eliminated about  jobs or less than  of its global workforce of  employees as part of a reorganization